Pricing Log in Create free account
Wednesday 14 October 2026 Export MOH’s income statement to Excel — free account

Molina Healthcare, Inc

MOH Healthcare Healthcare Plans

Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

209.87 5.51 +2.70%
Market cap
$10.7B
P/E
0.0×
Fwd P/E
55.0×
Dividend yield
—
F-score
4/9
Altman Z
4.28
Beneish M
−1.99
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.10
Total sells 3.56
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — 1 — — — — — — — —
Sell 1 — — — 1 — 2 — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 10,670.00
Revenue 44,522.00
Net Income (7.00)
Free Cash Flow 271.00
Net Debt (4,962.00)
Current Ratio 1.68 (at or above 1.5: strong)
Debt/Equity 0.95
P/E ratio 0.00
Fwd P/E 55.00 (above 35: high)
P/S ratio 0.24
P/B ratio 2.57
Past 5Y EPS Growth (4.50%) (below 0%: weak)
This Y EPS Growth (52.49%) (below 0%: weak)
Next Y EPS Growth 85.53% (at or above 15%: strong)
Next Y revenue growth (2.14%) (below 0%: weak)
Next 5Y EPS Growth 7.01%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.1×, against a ten-year median of 0.3×; over the ten years it ranged from −0.1× in 2017 to 0.5× in 2020.
P/S against its own 10 years 30.89%
10-year low 10-year high
P/B against its own 10 years 26.83%
10-year low 10-year high
EV/Sales against its own 10 years 31.15%
10-year low 10-year high
EV/FCF against its own 10 years 86.14%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 9,107 8,987 8,256 8,915
Receivables 3,104 3,299 3,533 3,485
Inventory — — — —
Other — — — —
12,542 12,773 12,444 12,928
2023 2024 2025 Q'26
Payables 1,252 1,331 1,093 1,139
ST’ Debt — — — —
Other 2,294 1,874 1,326 1,651
8,168 7,896 7,372 7,700

Compound Annual Growth %

10y 5y 3y
Sales 12.35% 18.52% 12.42%
Cash Flow 0.00% 0.00% 0.00%
Earnings 12.68% (6.85%) (15.85%)
Book Value 10.08% 14.19% 11.14%

Revenue $m

Mar Jun Sep Dec Year
’26 10,796 10,874 — — —
’25 11,147 11,427 11,477 11,375 45,426
’24 9,931 9,880 10,340 10,499 40,650
’23 8,149 8,327 8,548 9,048 34,072
’22 7,770 8,054 7,927 8,223 31,974
’21 6,522 6,800 7,040 7,409 27,771
’20 4,549 4,618 5,021 5,235 19,423
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 1,082 (294) — — —
’25 190 (302) (125) (298) (535)
’24 214 (219) 873 (224) 644
’23 916 487 949 (690) 1,662
’22 363 368 254 (212) 773
’21 568 493 461 597 2,119
’20 143 614 (158) 1,299 1,898
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 1,055 (324) — — —
’25 168 (344) (163) (297) (636)
’24 187 (246) 838 (235) 544
’23 884 456 923 (685) 1,578
’22 340 341 223 (222) 682
’21 552 480 434 576 2,042
’20 122 590 (177) 1,289 1,824
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.27 1.19 — — —
’25 5.45 4.75 1.51 (3.15) 8.92
’24 5.17 5.17 5.65 4.44 20.42
’23 5.52 5.35 4.21 3.70 18.77
’22 4.39 4.25 3.95 0.96 13.55
’21 3.89 3.16 2.46 1.74 11.25
’20 2.92 4.65 3.10 0.56 11.23
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 44.50 42.56 71.07 105.28 102.85 199.81 249.78 256.19 272.69 133.40

Analyst estimates 2026–2028

Powerpack
High 67.87 80.74 154.06 159.00 224.00 328.11 374.00 384.72 423.92 359.97
People
People Employees 21,000 20,000 11,000 10,000 10,500 14,000 15,000 123,123 18,000 19,000
Revenue/emp, $m 0.85 0.99 1.72 1.68 1.85 1.98 2.13 0.28 2.26 2.39
Income, $m
Income, $m Revenue 17,782 19,883 18,890 16,829 19,423 27,771 31,974 34,072 40,650 45,426
Gross margin, % 14.19 11.66 17.94 17.37 18.55 14.64 15.01 15.86 15.31 13.07
EBT 205 (612) 999 972 961 875 1,063 1,464 1,589 589
EBT margin, % 1.15 (3.08) 5.29 5.78 4.95 3.15 3.32 4.30 3.91 1.30
Net income 52 (512) 707 737 673 659 792 1,091 1,179 472
Depreciation 182 210 127 89 88 131 176 171 186 195
Per share, $
Per share, $ Revenue 320.97 355.05 309.67 270.56 329.20 480.47 553.18 590.50 708.19 860.34
Earnings 0.94 (9.07) 10.61 11.47 11.23 11.25 13.55 18.78 20.42 8.92
Cash flow 12.15 14.36 (5.15) 6.98 32.17 36.66 13.37 28.80 11.22 (10.13)
Capex (3.18) (1.54) (0.49) (0.92) (1.25) (1.33) (1.57) (1.46) (1.74) (1.91)
Free cash flow 8.97 12.82 (5.64) 6.06 30.92 35.33 11.80 27.35 9.48 (12.05)
Book value 29.77 23.88 27.00 31.51 35.53 45.50 51.28 73.05 78.33 77.06
Shares, m 55 56 61 62 59 58 58 58 57 53
Valuation, ×
Valuation, × P/E 58.10 0.00 11.00 11.83 18.94 28.27 23.54 19.78 14.25 20.27
P/S 0.17 0.22 0.38 0.50 0.65 0.66 0.58 0.63 0.41 0.20
P/B 1.80 3.27 4.30 4.31 5.99 6.99 6.22 5.09 3.72 2.25
EV/Sales 0.00 0.03 0.21 0.33 0.46 0.47 0.42 0.43 0.27 0.11
EV/FCF 0.07 0.92 (11.75) 14.66 4.88 6.45 19.57 9.34 19.97 (7.68)
Cash, $m
Cash, $m Operating cash flow 673 804 (314) 434 1,898 2,119 773 1,662 644 (535)
Capex (176) (86) (30) (57) (74) (77) (91) (84) (100) (101)
Free cash flow 497 718 (344) 377 1,824 2,042 682 1,578 544 (636)
Balance, $m
Balance, $m Working capital 1,418 1,954 2,216 2,698 2,911 3,017 3,229 4,374 4,877 5,072
Total debt 1,645 2,169 1,458 1,468 2,352 2,392 2,391 2,385 3,118 3,950
Net debt (2,932) (3,710) (3,049) (2,930) (3,677) (5,248) (5,114) (6,722) (5,869) (4,306)
Shareholders’ equity 1,649 1,337 1,647 1,960 2,096 2,630 2,964 4,215 4,496 4,069
Returns, %
Returns, % ROA 0.74 (6.43) 9.05 10.57 8.25 6.06 6.46 8.02 7.73 3.03
ROIC 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 3.24 (34.29) 47.39 40.86 33.19 27.89 28.32 30.39 27.07 11.02
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Molina Healthcare, Inc vs peers in Healthcare Plans (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ELV Elevance Health, Inc. $91.5B 18.8× 20.3× +1.40% (above 0%: growing) −13.08% (below 0%: shrinking) −9.01% (below 0%: shrinking) 15.77% 4.56% Compare
CI Cigna Group $74.9B 11.7× 11.4× +6.68% (above 0%: growing) +10.16% (above 0%: growing) +66.93% (above 0%: growing) 88.24% 3.73% Compare
HUM Humana Inc. $52.1B 39.5× 42.9× +26.18% (above 0%: growing) +27.88% (above 0%: growing) +58.51% (above 0%: growing) 13.45% 3.33% Compare
CNC Centene Corporation $33.1B — (loss-making) 24.8× +9.92% (above 0%: growing) n/m +116.61% (above 0%: growing) 8.59% 2.24% Compare
MOH Molina Healthcare, Inc $10.7B — (loss-making) 55.0× −4.84% (below 0%: shrinking) −74.95% (below 0%: shrinking) +5.81% (above 0%: growing) 13.19% 1.33%
OSCR Oscar Health, Inc. $10.5B 19.8× 29.7× +70.40% (above 0%: growing) n/m +316.29% (above 0%: growing) 22.25% 7.96% Compare
CLOV Clover Health Investments, Corp. $2.5B — (loss-making) 292× +55.60% (above 0%: growing) n/m +406.43% (above 0%: growing) 20.59% 3.77% Compare
PGNY Progyny, Inc. $2.2B 28.2× 19.9× +5.30% (above 0%: growing) +80.00% (above 0%: growing) −12.01% (below 0%: shrinking) 25.48% 11.41% Compare
ALHC Alignment Healthcare, Inc. $1.7B 39.5× 80.3× +31.55% (above 0%: growing) +125.00% (above 0%: growing) −229.51% (below 0%: shrinking) 13.55% 3.15% Compare
Median of peers $21.8B 24.0× 27.3× +18.05% +27.88% +62.72% 18.18% 3.75%

All 12 Healthcare Plans stocks →

Molina Healthcare, Inc (MOH) key facts

  • Strength: Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
  • Molina Healthcare, Inc (MOH) is a Healthcare Plans company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 13, 2026, MOH traded at $209.87, a market capitalization of $10.7 billion.
  • Return on equity was 11.0% and debt-to-equity 0.95.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 4.28 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Molina Healthcare, Inc (MOH) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/MOH · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com